Approval of Schemes of Dhanuka Employee Stock Option Plan 2026 and Dhanuka Stock Appreciation Rights Plan , 2026
DHANUKA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Dhanuka Agritech reported FY26 audited results with Total Income of Rs 2,062.80 Cr (vs Rs 2,071.26 Cr in FY25), Profit Before Tax of Rs 378.56 Cr (vs Rs 392.14 Cr), and Net Profit of Rs 287.23 Cr (vs Rs 296.96 Cr) - showing a marginal decline year-on-year. Q4 standalone revenue was Rs 483.34 Cr. The Board approved a Rs 70 Crore share buyback (5 lakh shares at Rs 1,400/share representing 1.11% of capital) via tender offer route with record date May 29, 2026; promoters intend to participate. Two employee incentive schemes were approved: ESOP 2026 (up to 50,000 options, 0.11%) and SARs 2026 (up to 125,000 rights, 0.28%), both pending shareholder approval at the August 3, 2026 AGM. A final dividend of 100% (Rs 2 per share) was recommended with record date July 17, 2026. The company also approved setting up wholly-owned subsidiaries in Brazil and a European country (initial investment Rs 1 Crore each) to manage Bayer brand transfers and new product registrations internationally. Senior management retirement of Mr. K.B. Kejariwal was noted.
The stock buyback at Rs 1,400/share signals management confidence as it represents a significant premium. Marginal profit decline despite stable revenue warrants monitoring. International expansion into Brazil and Europe could open new revenue streams but adds execution risk. The multiple shareholder-friendly actions (buyback + dividend) are positive signals for investor returns.